TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

  1. Home
  2. purchase Customization

purchase customization

Leave This Empty:

choose chapter to purchase


Back to Report

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of AAV Vector Gene Therapy
1.2 Key Market Segments
1.2.1 AAV Vector Gene Therapy Segment by Type
1.2.2 AAV Vector Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AAV Vector Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global AAV Vector Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global AAV Vector Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AAV Vector Gene Therapy Market Competitive Landscape
3.1 Global AAV Vector Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global AAV Vector Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 AAV Vector Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global AAV Vector Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers AAV Vector Gene Therapy Sales Sites, Area Served, Product Type
3.6 AAV Vector Gene Therapy Market Competitive Situation and Trends
3.6.1 AAV Vector Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest AAV Vector Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 AAV Vector Gene Therapy Industry Chain Analysis
4.1 AAV Vector Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of AAV Vector Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 AAV Vector Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AAV Vector Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global AAV Vector Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global AAV Vector Gene Therapy Price by Type (2019-2024)
7 AAV Vector Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AAV Vector Gene Therapy Market Sales by Application (2019-2024)
7.3 Global AAV Vector Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global AAV Vector Gene Therapy Sales Growth Rate by Application (2019-2024)
8 AAV Vector Gene Therapy Market Segmentation by Region
8.1 Global AAV Vector Gene Therapy Sales by Region
8.1.1 Global AAV Vector Gene Therapy Sales by Region
8.1.2 Global AAV Vector Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America AAV Vector Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe AAV Vector Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific AAV Vector Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America AAV Vector Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa AAV Vector Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 uniQure
9.1.1 uniQure AAV Vector Gene Therapy Basic Information
9.1.2 uniQure AAV Vector Gene Therapy Product Overview
9.1.3 uniQure AAV Vector Gene Therapy Product Market Performance
9.1.4 uniQure Business Overview
9.1.5 uniQure AAV Vector Gene Therapy SWOT Analysis
9.1.6 uniQure Recent Developments
9.2 Roche
9.2.1 Roche AAV Vector Gene Therapy Basic Information
9.2.2 Roche AAV Vector Gene Therapy Product Overview
9.2.3 Roche AAV Vector Gene Therapy Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche AAV Vector Gene Therapy SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Novartis
9.3.1 Novartis AAV Vector Gene Therapy Basic Information
9.3.2 Novartis AAV Vector Gene Therapy Product Overview
9.3.3 Novartis AAV Vector Gene Therapy Product Market Performance
9.3.4 Novartis AAV Vector Gene Therapy SWOT Analysis
9.3.5 Novartis Business Overview
9.3.6 Novartis Recent Developments
9.4 BioMarin Pharmaceutical
9.4.1 BioMarin Pharmaceutical AAV Vector Gene Therapy Basic Information
9.4.2 BioMarin Pharmaceutical AAV Vector Gene Therapy Product Overview
9.4.3 BioMarin Pharmaceutical AAV Vector Gene Therapy Product Market Performance
9.4.4 BioMarin Pharmaceutical Business Overview
9.4.5 BioMarin Pharmaceutical Recent Developments
9.5 Ferring Pharmaceuticals A/S
9.5.1 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Basic Information
9.5.2 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product Overview
9.5.3 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product Market Performance
9.5.4 Ferring Pharmaceuticals A/S Business Overview
9.5.5 Ferring Pharmaceuticals A/S Recent Developments
9.6 CSL Behring LLC
9.6.1 CSL Behring LLC AAV Vector Gene Therapy Basic Information
9.6.2 CSL Behring LLC AAV Vector Gene Therapy Product Overview
9.6.3 CSL Behring LLC AAV Vector Gene Therapy Product Market Performance
9.6.4 CSL Behring LLC Business Overview
9.6.5 CSL Behring LLC Recent Developments
9.7 PTC Therapeutics, Inc.
9.7.1 PTC Therapeutics, Inc. AAV Vector Gene Therapy Basic Information
9.7.2 PTC Therapeutics, Inc. AAV Vector Gene Therapy Product Overview
9.7.3 PTC Therapeutics, Inc. AAV Vector Gene Therapy Product Market Performance
9.7.4 PTC Therapeutics, Inc. Business Overview
9.7.5 PTC Therapeutics, Inc. Recent Developments
9.8 Pfizer Inc.
9.8.1 Pfizer Inc. AAV Vector Gene Therapy Basic Information
9.8.2 Pfizer Inc. AAV Vector Gene Therapy Product Overview
9.8.3 Pfizer Inc. AAV Vector Gene Therapy Product Market Performance
9.8.4 Pfizer Inc. Business Overview
9.8.5 Pfizer Inc. Recent Developments
10 AAV Vector Gene Therapy Market Forecast by Region
10.1 Global AAV Vector Gene Therapy Market Size Forecast
10.2 Global AAV Vector Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe AAV Vector Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific AAV Vector Gene Therapy Market Size Forecast by Region
10.2.4 South America AAV Vector Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of AAV Vector Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global AAV Vector Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of AAV Vector Gene Therapy by Type (2025-2030)
11.1.2 Global AAV Vector Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of AAV Vector Gene Therapy by Type (2025-2030)
11.2 Global AAV Vector Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global AAV Vector Gene Therapy Sales (K Units) Forecast by Application
11.2.2 Global AAV Vector Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings